MondayJun 11, 2018 11:56 am

Xanthic Biopharma, Inc. (CSE: XTHC) Pursues Profitability in 2019 by Expanding Marketing of Cannabinoid-Infused Powders via Strategic Partners

xTHC produces cannabinoid-infused drink powders from a non-cannabis and non-hemp source using a patent-pending process Business model is to be a first-mover and expand into more U.S. states, with the focus now on the California market; goal is to reach broad-based retail channels, not only dispensaries Company is partnering with and is minority owner of Oregon-based Avitas CBD Water, LLC (now renamed Xanthic Beverages) Xanthic Biopharma, Inc. (CSE: XTHC), on its initial investor conference call, projected multi-million dollar revenue and profitability in 2019 as it grows. It is a manufacturer of CBD-infused drink powder from a non-cannabis and non-hemp, economically…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered